APRECIA PHARMACEUTICALS
Aprecia Pharmaceuticals Company develops and manufactures precision drug delivery systems and products. Its products include CustomRelease that provides various time release profiles; ZipDose, a orally dispersing wafers pairing a high dose ceiling with times, taste-masking options, and IR/ER combinations; and NanoDose that is suited for products requiring submilligram doses. The company also offers ImplantaDose, which is suited for post surgical management of infections and associated pain, and sequential release of biomimetic proteins and peptides. Aprecia Pharmaceuticals Company was incorproated in 2003 and is based in Langhorne, Pennsylvania.
APRECIA PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2003-01-01
Address:
Langhorne, Pennsylvania, United States
Country:
United States
Website Url:
http://www.aprecia.com
Total Employee:
11+
Status:
Active
Contact:
(513) 984-5000
Email Addresses:
[email protected]
Total Funding:
158.42 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Domain Not Resolving Amazon
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Corium International
Corium International engages in the development of advanced transdermal drug delivery technologies and products.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
ANDE
ANDE specializes in designing rapid DNA analysis products and services.
Current Advisors List
Current Employees Featured
Investors List
Hercules Capital
Hercules Capital investment in Debt Financing - Aprecia Pharmaceuticals
Deerfield
Deerfield investment in Venture Round - Aprecia Pharmaceuticals
Alpha Capital
Alpha Capital investment in Venture Round - Aprecia Pharmaceuticals
Harbor View Advisors
Harbor View Advisors investment in Venture Round - Aprecia Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2020-01-30 | Aprecia Appoints Amol Matharu Chief Scientific Officer |
Official Site Inspections
http://www.aprecia.com Semrush global rank: 2.79 M Semrush visits lastest month: 5.8 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Aprecia Pharmaceuticals" on Search Engine
Aprecia Pharmaceuticals - Crunchbase Company Profile & Funding
About. Aprecia Pharmaceuticals develops precision drug delivery systems and products. Langhorne, Pennsylvania, United States. 51-100. Debt Financing. Private. …See details»
Aprecia Names Industry Leader Owen Murray as Its CEO
Blue Ash, Ohio – Jan 30th, 2023 - Aprecia Pharmaceuticals today announced Owen Murray as its Chief Executive Officer. Murray will lead the expansion of Aprecia’s …See details»
Aprecia Pharmaceuticals | LinkedIn
Aprecia Pharmaceuticals | 5,497 followers on LinkedIn. The 3DP Pharmaceutical Company | Aprecia, The 3DP Pharmaceutical Company, expects to use its ZipDose® …See details»
Aprecia Names Industry Leader Owen Murray as Its CEO - PR …
Jan 30, 2023, 11:32 ET. Share this article. BLUE ASH, Ohio, Jan. 30, 2023 /PRNewswire/ -- Aprecia Pharmaceuticals today announced Owen Murray as its Chief Executive …See details»
Aprecia (Drug Delivery) - PitchBook
Dec 10, 2013 Information on valuation, funding, cap tables, investors, and executives for Aprecia (Drug Delivery). Use the PitchBook Platform to explore the full profile.See details»
$35 Million to Fund Drug 3D Printing from Aprecia
Apr 2, 2024 After becoming the first company to obtain FDA approval for a 3D printed medication last August, Aprecia Pharmaceuticals Company, Inc. has announced the …See details»
APRECIA – The 3DP Pharmaceutical Company
APRECIA – The 3DP Pharmaceutical Company. Since 2004, Aprecia has been pioneering the technology of 3-Dimensional Printing (3DP) for pharmaceutical …See details»
Aprecia partners with Battelle to scale up 3D printed …
Apr 2, 2024 Aprecia Pharmaceuticals, the company behind the first FDA approved 3D printed drug Spritam, has entered into a long-term collaboration with private non-profit research and development (R&D)...See details»
Aprecia Names Andrew Karazim as New Chief Commercial Officer
BLUE ASH, Ohio, Feb. 7, 2024 /PRNewswire/ -- Aprecia, the global leader in 3DP technology for commercial-scale pharmaceutical manufacturing, today announced …See details»
inVentiv Health and Aprecia Pharmaceuticals Form ... - Fierce …
Jun 8, 2014 Aprecia is a unique specialty pharmaceutical company built upon an innovative and proprietary three dimensional printing (3DP) technology platform. The …See details»
Merck, Aprecia, and FabRx on transitioning 3D printed …
Apr 2, 2024 At the head of the field, the commercial potential of 3D printed pharmaceuticals is already being realized by Aprecia, with the company having …See details»
Aprecia Pharmaceuticals - Funding, Financials, Valuation
Aprecia Pharmaceuticals is funded by 4 investors. Hercules Capital and Deerfield are the most recent investors. Aprecia Pharmaceuticals has a post-money valuation in the …See details»
3D powder bed tablet printing: From a R&D printer to a scalable …
Sep 1, 2023 We thank Aprecia Pharmaceuticals - Corporate HQ and the Netherlands Organization for Applied Scientific Research (TNO), department for additive …See details»
Aprecia Pharmaceuticals - Contacts, Employees, Board …
Aprecia Pharmaceuticals. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 12. Number of Board …See details»
inVentiv Health And Aprecia Pharmaceuticals Form Innovative …
Jun 4, 2014 BURLINGTON, Mass. and LANGHORNE, Pa., June 4, 2014 /PRNewswire/ -- inVentiv Health ("inVentiv"), a life science knowledge and services company, and …See details»
E. Thomas Arington - Executive Director @ Aprecia …
Overview. Number of Founded Organizations 1. CB Rank (Investor) 142,359. Primary Job Title Executive Director. Primary Organization. Aprecia Pharmaceuticals. Gender …See details»
News | Press Releases | Aprecia
Aprecia Pharmaceuticals today announced Owen Murray as its Chief Executive Officer who will lead the expansion of Aprecia’s offerings in proprietary 3D-Printed …See details»
Don Wetherhold - Crunchbase Person Profile
Don Wetherhold is the chief executive officer of Aprecia Pharmaceuticals, a U.S.-based company that develops and manufactures precision drug delivery systems and products. …See details»
Products - Aprecia
The first FDA Approved 3D Printed Drug. SPRITAM (levetiracetam) Tablets for Oral Suspension is the first FDA Approved 3D-Printed medication. Learn more at …See details»
Careers | Pharma Manufacturing Jobs | Aprecia
02-01-2024. Find opportunities for pharmaceutical manufacturing careers and pharmaceutical R&D jobs at Aprecia.See details»